Unveiling the mysteries of HER2-low expression in breast cancer: pathological response, prognosis, and expression level alterations.

World J Surg Oncol · 2024 · PMC11396454 · PMID 39267055

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

In comparison with those with HER2-0 expression ( P = 0.064), there was a favorable trend in OS in patients with HER2-low expression.

also in 714 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.